• Home
  • About
    • Overview
    • Sharing Data
    • ORCID
  • Help
  • History (3)
    • CCR5 inhibition prevents cardiac dysfunction in the SIV/macaque model of HIV.
    • Peers promoting physical activity among breast cancer survivors: A randomized controlled trial.
    • Toxicity and survival outcomes of hyperfractionated split-course reirradiation and daily concurrent chemotherapy in locoregionally recurrent, previously irradiated head and neck cancers.
    • See All 3 Pages
  • search
    • Find People
    • Find Everything
Login to edit your profile (add a photo, awards, links to other websites, etc.)
  • Edit My Profile
  • My Person List (0)

CCR5 inhibition prevents cardiac dysfunction in the SIV/macaque model of HIV.

CCR5 inhibition prevents cardiac dysfunction in the SIV/macaque model of HIV. J Am Heart Assoc. 2014 Apr 02; 3(2):e000874.

View in: PubMed

subject areas
  • Animals
  • CCR5 Receptor Antagonists
  • Cyclohexanes
  • Diastole
  • Disease Models, Animal
  • Echocardiography, Doppler
  • Heart Ventricles
  • HIV Fusion Inhibitors
  • Ligands
  • Macaca mulatta
  • Myocytes, Cardiac
  • Receptors, CCR5
  • Signal Transduction
  • Simian Acquired Immunodeficiency Syndrome
  • Triazoles
  • Ventricular Dysfunction
  • Ventricular Function
  • Viral Load

authors with profiles
  • Robert J. Adams